RCM macrocyclization made practical: an efficient synthesis of HCV protease inhibitor BILN 2061

Chutian Shu1, Xingzhong Zeng, Ming-Hong Hao

  • 1Department of Chemical Development, Boehringer Ingelheim Pharmaceuticals, 900 Ridgebury Road, Ridgefield Connecticut 06877, USA. chutian.shu@boehringer-ingelheim.com

Organic Letters
|February 26, 2008
PubMed